MAZE Stock: Price, Earnings History and SEC Filings
Maze Therapeutics, Inc. (MAZE) last traded at $31.48, down 1.41% on the latest session and up 15.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.76 against an analyst estimate of $-0.76, a beat of 0.0%.
$31.48 -1.41%
1 month+15.82%
52-week high$53.65
52-week low$21.95
Volume326,504
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
MAZE earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 11, 2026 | $-0.76 | $-0.76 | +0.00% |
| Mar 2026 | May 12, 2026 | $-0.45 | $-0.43 | -4.65% |
| Dec 2025 | Mar 25, 2026 | $-0.65 | $-0.73 | +10.96% |
| Sep 2025 | Nov 6, 2025 | $-0.66 | $-0.74 | +10.81% |
MAZE beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for MAZE
SEC filing data is not available right now. You can search for MAZE on SEC EDGAR.
MAZE news
- What Makes Maze Therapeutics, Inc. (MAZE) a New Buy StockOct 19, 2026 · finance.yahoo.com
- Intel upgraded, PayPal downgraded: Wall Street's top analyst callsOct 19, 2026 · finance.yahoo.com
- How Much Upside is Left in Maze Therapeutics, Inc. (MAZE)? Wall Street Analysts Think 123.39%Oct 19, 2026 · finance.yahoo.com
About Maze Therapeutics, Inc.
Maze Therapeutics, Inc. (MAZE) is a US-listed public company on Nasdaq.